The USA-based Healthcare Distribution Management Association has issued a message of support for the House of Representatives' Counterfeit Drug Prevention Act of 2009 (HR 1450), which raises criminal penalties for producing fake medicines from a range of one to three years imprisonment to 20 years or more. The group represents wholesalers of prescription medicines and other pharmacy supplies to 145,000 outlets, including hospitals, physician offices and pharmacies.
John Gray, the HDMA's president, said: "one of the most effective ways to deter dangerous counterfeiters is to increase criminal penalties so that the punishment fits the severity of the crime. I applaud Representatives Rogers and Green for introducing HR1450. The nation's primary, full-service distributors pledge to support this legislation and work toward its speedy enactment."
HR1450 was introduced by Reps Mike Rogers (Republican, Michigan) and Gene Green (Democrat, Texas) and is to be considered by both the House Energy and Commerce and House Judiciary Committees.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze